Literature DB >> 27057815

Meet me in the cytoplasm: A role for p27(Kip1) in the control of H-Ras.

Gustavo Baldassarre1, Barbara Belletti1.   

Abstract

The small GTPases of the Ras family play a pivotal role in the regulation of cell proliferation and motility, both in normal and transformed cells. In particular, the 3 genes encoding for the N-, H- and K-Ras are frequently mutated in human cancer and their inappropriate regulation, expression and subcellular localization can drive tumor onset and progression. Activation of the Ras-MAPK pathway directly signals on the cell cycle machinery by regulating the expression and/or localization of 2 key cell cycle player, Cyclin D1 and p27(Kip1). We recently reported that in normal fibroblasts, following mitogenic stimuli, p27(Kip1) translocates to the cytoplasm where it regulates H-Ras localization and activity. This regulatory mechanism ensures that cells pass beyond the restriction point of the cell cycle only when the proper level of stimulation is reached. Here, we comment on this new evidence that possibly represents one of the ways that cells have developed during evolution to ensure that the cell decision to divide is taken only when time and context are appropriate.

Entities:  

Keywords:  H-Ras; K-Ras; cell cycle; microtubule stability; motility; p27kip; proliferation; stathmin

Mesh:

Substances:

Year:  2016        PMID: 27057815      PMCID: PMC4905269          DOI: 10.1080/21541248.2016.1171279

Source DB:  PubMed          Journal:  Small GTPases        ISSN: 2154-1248


  31 in total

1.  New light on p27(kip1) in breast cancer.

Authors:  Barbara Belletti; Gustavo Baldassarre
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

Review 2.  Drugging the undruggable RAS: Mission possible?

Authors:  Adrienne D Cox; Stephen W Fesik; Alec C Kimmelman; Ji Luo; Channing J Der
Journal:  Nat Rev Drug Discov       Date:  2014-10-17       Impact factor: 84.694

3.  Genetic evidence for the interactions of cyclin D1 and p27(Kip1) in mice.

Authors:  W Tong; J W Pollard
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

4.  p27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability.

Authors:  Linda Fabris; Stefania Berton; Ilenia Pellizzari; Ilenia Segatto; Sara D'Andrea; Joshua Armenia; Riccardo Bomben; Monica Schiappacassi; Valter Gattei; Mark R Philips; Andrea Vecchione; Barbara Belletti; Gustavo Baldassarre
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-28       Impact factor: 11.205

5.  p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.

Authors:  Gustavo Baldassarre; Barbara Belletti; Milena S Nicoloso; Monica Schiappacassi; Andrea Vecchione; Paola Spessotto; Andrea Morrione; Vincenzo Canzonieri; Alfonso Colombatti
Journal:  Cancer Cell       Date:  2005-01       Impact factor: 31.743

6.  Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis.

Authors:  J Philipp; K Vo; K E Gurley; K Seidel; C J Kemp
Journal:  Oncogene       Date:  1999-08-19       Impact factor: 9.867

7.  p27Kip1 modulates cell migration through the regulation of RhoA activation.

Authors:  Arnaud Besson; Mark Gurian-West; Anja Schmidt; Alan Hall; James M Roberts
Journal:  Genes Dev       Date:  2004-04-12       Impact factor: 11.361

8.  Germline expression of H-Ras(G12V) causes neurological deficits associated to Costello syndrome.

Authors:  J Viosca; A J Schuhmacher; C Guerra; A Barco
Journal:  Genes Brain Behav       Date:  2008-09-22       Impact factor: 3.449

9.  Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice.

Authors:  Y Geng; Q Yu; E Sicinska; M Das; R T Bronson; P Sicinski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

10.  Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity.

Authors:  Melissa K James; Arpita Ray; Dina Leznova; Stacy W Blain
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 5.069

View more
  1 in total

1.  Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms.

Authors:  João Agostinho Machado-Neto; Bruna Alves Fenerich; Renata Scopim-Ribeiro; Christopher A Eide; Juan Luiz Coelho-Silva; Carlos Roberto Porto Dechandt; Jaqueline Cristina Fernandes; Ana Paula Nunes Rodrigues Alves; Priscila Santos Scheucher; Belinda Pinto Simões; Luciane Carla Alberici; Lorena Lôbo de Figueiredo Pontes; Cristina E Tognon; Brian J Druker; Eduardo Magalhães Rego; Fabiola Traina
Journal:  Cell Death Dis       Date:  2018-02-22       Impact factor: 8.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.